PERSISTENT EXPERIMENTATION


in unique and novel ways that we hadn’t even conceived. Tat’s very informative.”


Te Office of the Principal Assistant for Acquisition (OPAA)—under the guidance of Nuckols, Acquisition Workforce Devel- opment Manager Eva Rosvold and Science Adviser Joan Cmarik, Ph.D.—manages and coordinates USAMRDC participa- tion in events sponsored by the capability development integration directorates, the Rapid Capabilities and Critical Technolo- gies Office, program executive offices and similar organizations. A representative from the Office of the Principal Assistant for Research and Technology, OPAA’s counterpart on the research and develop- ment side of the organization, manages and coordinates USAMRDC’s participa- tion in the AFC’s Future Studies Program and focused excursions.


To organize participation in these events, the Experimentation Integration Cell maintains relationships with the Futures and Concepts Center and the Medi- cal Capability Development Integration Directorate. It also actively seeks oppor- tunities to build relationships with new partners to facilitate participation in other events. Tis increased access significantly benefits USAMRDC scientists seeking venues to test and refine their new capa- bilities.


BENEFITS OF THE EI CELL APPROACH Te EI Cell has quickly found its niche as a joint interagency capability by enabling USAMRDC’s DRUs to “piggyback” on training exercises in ways that are both complementary and mutually beneficial to the experimenters and exercise spon- sors and ultimately to the warfighter. By consolidating previously disparate efforts, serving as a single, consistent and reliable point of contact for medical experiment- ers and exercise sponsors and providing


24 Army AL&T Magazine Summer 2024


logistical support to experimentation teams before, during and after events, the EI Cell significantly improves the agil- ity of USAMRDC to seize opportunities to participate in unique experimentation events that lead to more and better testing of new and improved medical capabilities.


“We define our role as making sure that we have the right products at the right type of events at the right time in their


maturity or development,” says Rosvold. “Tis involves being a linchpin between the experimentation sponsors and DRUs. A lot of last-minute requirements and requests for information come up as an event progresses that can be complicated or confusing to understand. We help serve as a clearinghouse and help determine exactly what is needed from the DRU or sponsor.”


HAVE TRUNK, WILL TEST


Capt. Ian Davis of USAMRIID’s Diagnostic Systems Division conducts baseline testing in extreme cold weather at JBER during Arctic Edge 2024. With support from USAMRDC’s EI Cell, the Diagnostic Systems Division plans to test new capabilities in next year’s Arctic Edge exercise.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148